Heather CallaghanActivist Post
University of Calgary's Hotchkiss Brain Institute (HBI) researchers actually made a few notable discoveries while creating a new drug for brain cancer treatment. Even though their focus is on new drug trials, perhaps because they were funded by Alberta Innovates – Health Solutions/Alberta Cancer Foundation, this writer found their discoveries noteworthy.
Modern treatments for the most aggressive brain cancer, called glioblastoma, leave suffering patients with abysmal survival rates. A median survival rate after conventional treatment might be 15 months with less than 5% of patients living beyond five years.
A mechanism in brain cancer progression has been identified, and with it, some more insight about defense.
